Food and Drug Administration grant notices posted in 2022, now closed
42 Food and Drug Administration grant notices posted on Grants.gov in 2022 that have closed, with their numbers and dates.
- RFA-FD-23-021: Cooperative Agreement to Support the Western Center for Food Safety (U19) Clinical Trials Not Allowed
- RFA-FD-23-006: Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01) Clinical Trial Optional
- RFA-FD-23-025: Supporting the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
- PAR-23-072: FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
- RFA-FD-23-014: In Vivo Regional Deposition Measurements for Supporting Model Validation (U01) Clinical Trial Required
- RFA-FD-23-008: Novel approaches to support therapeutic development in ultra-rare cancers
- RFA-FD-23-016: Designing and performing a virtual bioequivalence trial for physiologically-based pharmacokinetic and other mechanism-based models
- RFA-FD-23-013: Evaluation of oral modified release drug tablet to support the approval of additional strengths
- RFA-FD-23-017: Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed
- RFA-FD-23-012: Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
- RFA-FD-23-023: Cooperative Agreement to Support Regulatory Research Related to the 2023 Prescription Drug User Fee Act
- RFA-FD-23-018: Assuring Radiation Protection (U18) Clinical Trial Not Allowed
- RFA-FD-23-009: Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Not Allowed
- RFA-FD-23-003: Building Research Capacity in Global Tobacco Product Regulation Program (U18) Clinical Trials Not Allowed
- RFA-FD-23-004: Centers of Excellence in Regulatory Science and Innovation (CERSI)
- RFA-FD-23-005: OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
- RFA-FD-23-002: Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24) Clinical Trials Not Allowed
- RFA-FD-23-001: Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required
- RFA-FD-22-027: Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Prescribing of Benzodiazepines
- RFA-FD-22-028: Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Treatment of Obstetrics Pain
- RFA-FD-22-020: OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Optional
- RFA-FD-22-005: Funding Opportunity Title Innovation Award: Minority Health and Health Equity (U01) Clinical Trials Optional
- RFA-FD-22-026: Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional
- RFA-FD-22-024: Renewal- Local Food Producer Outreach, Education, and Training to Enhance Food Safety and FDA Food Safety Modernization Act (FSMA) Compliance (U01) Clinical Trail Not Allowed
- RFA-FD-22-025: Renewal - Native American Tribes Outreach, Education, and Training to Enhance Food Safety and FSMA Compliance (U01) Clinical Trial Not Allowed
- RFA-FD-22-008: Retail Food Safety Regulatory Association Collaboration (U18) [Clinical Trial Not Allowed]
- RFA-FD-22-023: Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) (U01) Clinical Trial Not Allowed)
- RFA-FD-22-009: Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs (U2F) Clinical Trials Not Allowed
- RFA-FD-22-010: Revision Applications - Development and Maintenance of the Animal Feed Regulatory Program Standards Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18) [Clinical Trials Not Allowed]
- RFA-FD-22-019: Revision Applications - Manufactured Food Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18) [Clinical Trials Not Allowed]
- PAR-22-108: Innovative ways to provide education on antimicrobial stewardship practices in animals.
- RFA-FD-22-014: In Vitro Based Approaches to Evaluate the Bioequivalence of Generic Rectal and Vaginal Products
- RFA-FD-22-017: Cutaneous pharamcokinetic-based approaches to establish bioequivalence of topically applied drug products
- RFA-FD-22-018: Investigating the in vivo behavior and in vitro characteristics purportedly gastro-retentive extended release formulation to enhance the regulatory standard of such products
- RFA-FD-22-012: PBPK modeling to support assessment of bioequivalence of locally acting drugs in the gastrointestinal tract
- RFA-FD-22-013: Development of advanced analytical methods for the characterization of complex generics
- RFA-FD-22-015: In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems (TDS) (U01) Clinical Trial Required
- RFA-FD-22-016: Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional
- RFA-FD-22-022: Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed)
- RFA-FD-22-021: Building an Integrated Information Technology Infrastructure for State Regulatory Programs (U2F) [Clinical Trial Not Allowed]
- PAR-22-087: Research to support the development of alternatives to antimicrobials for use in food-producing animals
- PAR-22-063: CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18) Clinical Trials